A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

August 31, 2016

Conditions
Atrial Fibrillation
Interventions
OTHER

Conventional cryotherapy dosage

Cryotherapy dosage: 180 seconds applications until block of the pulmonary vein plus 1 bonus freezing of 180 seconds

OTHER

Experimental cryotherapy dosage

"cryotherapy dosage: applications time to block of the vein plus 60 seconds long until block of the vein plus 1 bonus freezing of 120 seconds"

DEVICE

Arctic Front Advance ST Cryoenergy Balloon Catheter

Electrical isolation of pulmonary veins with Arctic Front Advance cryoballoon

DRUG

Adenosine triphosphate

12 mg of adenosine triphosphate are administrated intravenously to test dormant conduction in pulmonary veins apparently disconnected

DEVICE

nECG platform Nuubo®

30 days electrocardiographic monitoring system to detect atrial fibrillation episodes after ablation

Trial Locations (1)

46010

Hospital Clínico Universitario de Valencia, Valencia

All Listed Sponsors
lead

Fundación para la Investigación del Hospital Clínico de Valencia

OTHER

NCT02789358 - A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation | Biotech Hunter | Biotech Hunter